198 filings
Page 5 of 10
424B4
7wl4 7iwblqxrs
15 May 19
Prospectus supplement with pricing info
4:47pm
8-K
oipz382csa6dty
8 May 19
Regulation FD Disclosure
8:50am
8-K
r7cseq pvx1n
30 Apr 19
Evolus Reports First Quarter 2019 Financial Results
4:03pm
DEFA14A
8tdsd1v9
29 Apr 19
Additional proxy soliciting materials
5:08pm
DEF 14A
bp8vugetlnjkk
29 Apr 19
Definitive proxy
5:06pm
8-K
acwr7
26 Apr 19
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
9:01am
EFFECT
42r 5gaiwa0vhk
16 Apr 19
Notice of effectiveness
12:15am
CORRESP
oavtgdxe4qa4nrf
11 Apr 19
Correspondence with SEC
12:00am
S-3/A
b883f6je91b3utckz8gk
10 Apr 19
Shelf registration (amended)
6:33am
CORRESP
ffedswk
10 Apr 19
Correspondence with SEC
12:00am
UPLOAD
k8hbo7
4 Apr 19
Letter from SEC
12:00am
8-K
v4ktbr 4h72blnkm
1 Apr 19
Evolus Provides Regulatory Update on Nuceiva™ in the European Union
9:05am
S-3
jcdse7
22 Mar 19
Shelf registration
4:56pm
8-K
doeci3yvvf8iu7oemgce
18 Mar 19
Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC
4:05pm
SC 13G
d4cbplot3l amk8
14 Feb 19
Evolus, Inc.
4:28pm
SC 13G
h4u3 q0h1uph85b1nuv
12 Feb 19
Evolus, Inc.
9:38am
4
18rgna ljd1cfmq
25 Jan 19
Evolus / Rui Avelar ownership change
8:22pm
4
ognn8qeb 26jx3wzyrur
25 Jan 19
Evolus / Michael M. Jafar ownership change
8:22pm